Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Anyang Second Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical manufacturer and a subsidiary of the Jointown Pharmaceutical Group. Established in 1954, the company has evolved from a state-owned factory into a modern enterprise specializing in the production of chemical active pharmaceutical ingredients (APIs) and various finished dosage forms. Its extensive product portfolio includes analgesics, antibiotics, and treatments for cardiovascular and gastrointestinal disorders, with key products such as Paracetamol and Metronidazole. The company operates large-scale, GMP-certified manufacturing facilities in Anyang, Henan Province, supporting both domestic supply and international exports. As part of the Jointown network, it leverages extensive distribution capabilities to maintain a significant presence in the healthcare market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Anyang Second Pharmaceutical.